8-11 June 2016
AstraZeneca and MedImmune share lupus news at EULAR 2016
Each year, the European League Against Rheumatism organises the EULAR Congress, where thousands of health care professionals convene to discuss the latest scientific advancements in the rheumatology field. AstraZeneca and MedImmune will highlight data on our investigational monoclonal antibody anifrolumab for systemic lupus erythematosus (SLE) at the EULAR 2016 taking place in London, UK from 8-11 June, 2016.
Page Atlas ID: 989824.011
Date of next review: June 2017